Tacrolimus And The Risk Of Graft Rejection Due To Medication Errors: Inadvertent Switching Between Different Oral Formulations
Recall Summary Tacrolimus oral medications are being recalled across Canada because patients may accidentally receive the wrong formulation due to packaging or labeling that could cause confusion between different types. This medication error could lead to graft rejection in transplant patients who need precise dosing. The recall affects people taking tacrolimus orally for organ transplant maintenance.
- Reason
- Product safety
- Category
- drug recall
- Country
- Canada
- Agency
- HC-DRUGS
- Recall date
- 2019-07-22
- Status
- Ongoing
- Distribution
- Canada-wide
Official recall notice from HC-DRUGS
Recall details on Nibble Recalls: https://trynibble.app/recalls/a94cb4a3-9cd2-4ae6-a659-74c17c4de133